Trial Outcomes & Findings for Analgetic and Anxiolytic Effect of Preoperative Pregabalin (NCT NCT00353704)
NCT ID: NCT00353704
Last Updated: 2011-07-20
Results Overview
The visual analogue scale (VAS) was used for registration of the pain intensity at rest. The score ranges from 0-100, where 0 means no pain and 100 means maximal pain. Higher values represent a worse outcome.
COMPLETED
PHASE4
50 participants
120 minutes after surgery
2011-07-20
Participant Flow
recruitment period november 2005 until june 2008
Participant milestones
| Measure |
Pregabalin
|
Placebo
|
|---|---|---|
|
Overall Study
STARTED
|
25
|
25
|
|
Overall Study
COMPLETED
|
22
|
24
|
|
Overall Study
NOT COMPLETED
|
3
|
1
|
Reasons for withdrawal
| Measure |
Pregabalin
|
Placebo
|
|---|---|---|
|
Overall Study
Protocol Violation
|
3
|
1
|
Baseline Characteristics
Analgetic and Anxiolytic Effect of Preoperative Pregabalin
Baseline characteristics by cohort
| Measure |
Pregabalin
n=25 Participants
|
Placebo
n=25 Participants
|
Total
n=50 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
25 Participants
n=5 Participants
|
25 Participants
n=7 Participants
|
50 Participants
n=5 Participants
|
|
Age Continuous
|
44 years
STANDARD_DEVIATION 11 • n=5 Participants
|
43 years
STANDARD_DEVIATION 8 • n=7 Participants
|
43 years
STANDARD_DEVIATION 10 • n=5 Participants
|
|
Sex: Female, Male
Female
|
12 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
24 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
13 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
26 Participants
n=5 Participants
|
|
Region of Enrollment
Norway
|
25 participants
n=5 Participants
|
25 participants
n=7 Participants
|
50 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 120 minutes after surgeryThe visual analogue scale (VAS) was used for registration of the pain intensity at rest. The score ranges from 0-100, where 0 means no pain and 100 means maximal pain. Higher values represent a worse outcome.
Outcome measures
| Measure |
Pregabalin
n=22 Participants
|
Placebo
n=24 Participants
|
|---|---|---|
|
Mean VAS Pain (Visual Analogue Scale)at Rest (0-100 mm)
|
11.7 Units on a scale
Standard Deviation 9.6
|
22.5 Units on a scale
Standard Deviation 14.4
|
SECONDARY outcome
Timeframe: 240 minutesPatients were equipped with a morphine PCA (patient controlled analgesia) for 24 hours after surgery. So they could administrate morphine intravenously by pressing a button. The sum of morphine was registered as " cumulated opioid consumption (milligram)
Outcome measures
| Measure |
Pregabalin
n=22 Participants
|
Placebo
n=24 Participants
|
|---|---|---|
|
Morphine (Opioid) Consumption Cumulated
|
7.3 mg
Standard Deviation 6.3
|
16.0 mg
Standard Deviation 13.2
|
Adverse Events
Pregabalin
Placebo
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place